Introduction
============

Hypertension is one of the major public health issues around the world and is among the major modifiable risk factors of cardiovascular diseases.[@b1-ppa-12-803],[@b2-ppa-12-803] The World Health Organization (WHO) reported that hypertension is estimated to have caused 9.4 million deaths and 7% of the disease burden in 2010, and the situation is still deteriorating.[@b3-ppa-12-803] In China, the prevalence of hypertension is 32.5%. About one-third of Chinese adults need antihypertensive treatment, but only 46.4% of them are being treated with anti-hypertensive medications, resulting in an overall control rate of 4.2%.[@b4-ppa-12-803] Nonadherence to antihypertensive medication is the main reason for the ineffective control of blood pressure. One study had shown that patients' adherence to their medication regimen reduces the risk of myocardial infarction by 20%--25%, cardiac failure by \>50%, and stroke by 35%--40%.[@b5-ppa-12-803] Nonadherence to medication regimens is common among patients with hypertension worldwide, especially in China, with nonadherence rate ranged from 40.3% to 78.7%.[@b6-ppa-12-803]--[@b10-ppa-12-803] Hence, the factors associated with adherence to antihypertensive medications have been a topic of interest.

Factors that affect adherence to antihypertensive medications are complex. The WHO classified those multidimensional factors into patient-, social/economic-, condition-, therapy-, and health care team-related factors.[@b11-ppa-12-803] Community management is the main factor that influences the effects of treatment and control of blood pressure in patients with hypertension. Fikri-Benbrahim et al conducted a survey in Spanish and found that medication adherence in patients with hypertension under the management of a community pharmacist is 4.07 times higher than those without management.[@b12-ppa-12-803] A study conducted in the USA showed that medication adherence increased by 36% through regular follow-ups, individualized education on medication by community pharmacists, and the use of blister packs in dispensing medications.[@b13-ppa-12-803] Two systematic reviews reported that medication management, educational interventions directed to the patients, and more frequent follow-up appointments or contacts were the most frequently used community management methods in many countries, effectively increasing the medication adherence of patients.[@b14-ppa-12-803],[@b15-ppa-12-803] In 2009, China launched new health care reforms, which include strategies that are closely linked with chronic disease control, including management of hypertension. Patients with hypertension aged ≥35 years were provided free management services by the local primary health care workers, including health records, free blood pressure measurement, regular follow-ups every 3 months, and health education.[@b16-ppa-12-803],[@b17-ppa-12-803]

Many studies were conducted to investigate the factors associated with medication adherence in community-managed patients with hypertension.[@b8-ppa-12-803],[@b18-ppa-12-803]--[@b25-ppa-12-803] Wang et al analyzed seven factors, including age, gender, and number of comorbidities, affecting the medication adherence among Chinese community-managed elderly patients with hypertension by using a multivariate linear regression model.[@b20-ppa-12-803] The same model was also used by Ma to analyze 13 factors, including age, gender, and medications used, associated with antihypertensive medication adherence in patients living in the rural areas of Shanxi, China.[@b8-ppa-12-803] Moreover, Bishopric et al analyzed 29 factors affecting the medication adherence of patients with hypertension living in a rural Vietnamese community by using a multiple logistic regression model.[@b19-ppa-12-803] Most studies used a regression model to analyze the multidimensional factors that affect the patients' adherence to antihypertensive medications.[@b26-ppa-12-803]--[@b31-ppa-12-803] Although these factors maybe correlated, it was difficult to propose a strategy to improve the measures for medication adherence using a unidimensional factor. On the other hand, a regression model could not solve the colinearity in complex factors. Thus, this study reduced dimensions to solve colinearity in multidimensional factors of medication adherence by using a principal component analysis method, which was convenient for policy makers to make future interventions.

Xinjiang is located in the northwestern region of China. In 2015, the per capita gross domestic product of Xinjiang was 40,036 yuan, and the number of general practitioners per 10,000 permanent populations were 1.25; it has an underdeveloped economy and has areas with relatively scanty health resources.[@b32-ppa-12-803],[@b33-ppa-12-803] The prevalence of hypertension in Xinjiang is 33.34%, which was higher than the national prevalence rate. However, the control rate is only 10.8%.[@b34-ppa-12-803] Prior studies reported that the prevalence of medication adherence among patients with hypertension in Xinjiang ranged from 34.0% to 53.5%, which was also higher than the national prevalence rate.[@b10-ppa-12-803],[@b35-ppa-12-803]--[@b40-ppa-12-803] The patients with hypertension in Xinjiang had poor medication adherence and blood pressure control. Thus, this study aimed to assess the relationship between factors and medication adherence in Xinjiang community-managed patients with hypertension using the principal component analysis, with a certain reference to other areas with underdeveloped economies and scanty health sources.

Patients and methods
====================

Sampling and settings
---------------------

We conducted a cross-sectional survey by using a self-designed questionnaire at three areas in Xinjiang, China, between April and August 2016. A total of 1,916 patients with hypertension participated in this study. Using a multi-stage sampling method based on the economic status and population size in Xinjiang, nine communities of the three areas were selected as samples. The following were the inclusion criteria of this study: individuals who 1) were diagnosed with hypertension by clinical doctors, 2) were managed by a community, 3) had a systolic blood pressure ≥140 mmHg and/or a diastolic blood pressure ≥90 mmHg, and 4) were taking at least one antihypertensive medication during the survey period. On the other hand, the exclusion criteria were as follows: those who 1) had communication difficulties such as visual impairment and poor hearing, 2) exhibited severe cognitive impairment or diagnosed with dementia and mental disorder, 3) were too sick to participate in this study, and 4) were uncooperative. A pilot study was conducted on one of the sampled community, which was composed of 159 patients with hypertension who were not included in the final study sample.

The sample size was calculated based on the number of participants required to maintain a statistical power for the statistical tests used in data analysis. Since there was no available literature showing the prevalence of adherence among the Xinjiang community in general, the following variables were used: an expected prevalence rate of 76%,[@b41-ppa-12-803] a two-sided, 0.05 significance level test with a 90% statistical power, and a minimum of 127 participants.

Questionnaire and definition of variables
-----------------------------------------

A self-designed questionnaire was used as a data collection tool, which was designed similar to that used in the extensive literature review of similar studies.[@b38-ppa-12-803],[@b42-ppa-12-803],[@b43-ppa-12-803] The questionnaire included: 1) patient's demographics such as age, sex, marital status, education, insurance, annual household income, and number of family members; 2) clinical characteristics such as health status, comorbidities, sickness status, and blood pressure control status; 3) patient's medication adherence; and 4) health services used such as outpatient visits, hospitalization visits, and emergency visits. The data were collected through a face-to-face interview, which lasted for an average of 15--20 minutes.

This study used the following self-report questions to measure the patient's medication adherence: 1) Can you take your antihypertensive medication everyday based on the frequency prescribed by doctors? 2) Can you take your antihypertensive medication everyday based on the timing prescribed by doctors? 3) Can you take your antihypertensive medication everyday based on the required dose prescribed by doctors? and 4) Do you continuously take your antihypertensive medication? The 4-scale answers of the first three questions include: 1) never complete, 2) sometimes complete, 3) usually complete, and 4) always complete. The patients were asked to select the following options to answer the last question: 1) discontinued the medication, 2) took the medications intermittently, 3) took the medications continuously but below the prescribed dose, and 4) took the medications continuously without interruption. The participants who chose either the third or the fourth options as answers to all four questions were identified as adherent; those who did not were considered as nonadherent.[@b44-ppa-12-803],[@b45-ppa-12-803] The standardized Cronbach's *α*, a measure of reliability, was a total of 0.804.

In addition, blood pressure control is considered as a binary variable; thus, patients with a systolic blood pressure \<140 mmHg and/or a diastolic blood pressure \<90 mmHg are regarded as having control over their blood.[@b42-ppa-12-803],[@b43-ppa-12-803] Regular clinical check was a binary variable, patients who were considered having regular clinical check should have at least once clinical check within 3 months, otherwise they were considered to have no regular clinical check. Regular blood pressure check was a dichotomous variable, patients with regular blood pressure check should measure their blood pressure at least once within a week, if not, they were considered to have no regular blood pressure check. Complication variable was divided into two categories based on whether patients had hypertension-related complications or not. Number of comorbidities was divided into three categories: having no comorbidity, having one or two comorbidities, and having more than three comorbidities. In this study, comorbidity was referred to other chronic diseases except hypertension. All patients were categorized as insured or uninsured for outpatient medical reimbursement policy. Duration was divided into three categories based on the time that patients were diagnosed with hypertension. Self-reported severity of hypertension was divided into four categories based on the patients' severity of their disease.

Data analysis
-------------

Statistical analyses were performed using the SPSS version 24.0. Frequencies and percentages were calculated for categorical variables. The categorical variables were tested using a univariate chi-square test. This study used a principal component analysis to transform some of the factors into aggregative indicators in order to eliminate the correlation between factors. A binary logistic regression analysis was used to evaluate the odds ratios of factors that showed a statistically significant association with the medication adherence in the univariate analysis. *P*-value \<0.05 was considered statistically significant.

Ethics statement
----------------

This study was approved by the Ethics Committee of the Shihezi University. The study was funded and permitted by the National Natural Science Foundation of China (project identification code: 71363047). The participants were assured that their answers in this study would not impact their subsequent benefits. Their personal information such as name, address, and identification number were collected to be used in the later follow-up studies, and all data are kept strictly confidential and secured. The data gathered are only used in this study. Investigators read and explained the informed consent, and all participants gave written informed consent (signed or fingerprinted if illiterate) before the questionnaire began.

Results
=======

Sample characteristics
----------------------

The demographic characteristics of the respondents are shown in [Table 1](#t1-ppa-12-803){ref-type="table"}; a total of 2,191 patients with hypertension participated in this study, with an effective response rate of 87.4%. However, the number of samples selected in this study was only a total of 1,916. Females accounted for 1,154 (60.2%) of the total samples. The average age of the total samples was 72.21±7.707 years (from 38 to 97 years). Most of them were living with more than one family member (87.2%) and some were married (79.3%). Most of them were retired (92.7%) and some of them availed the outpatient medical reimbursement policy (29.6%). Just one-third of the patients were either illiterate (37.9%) or only had attained primary education (33.0%), and one-tenth of them had attained high school education or above (10.5%). Using a bivariate analysis, this study found that age, residence, educational level, annual household income, and outpatient medical reimbursement were statistically associated with nonadherence (*P*\<0.05). Patients living in rural areas and those with no outpatient insurance reimbursement had significantly higher rates of nonadherence. Further comparison in each group was performed, and a statistical significant difference was revealed between the participants in the 35--64, 65--69, and 70--74 age groups (*χ*^2^=8.320, *P*=0.004; *χ*^2^=9.963, *P*=0.002). Patients aged \<70 years, those with a middle school degree, and those whose annual household income \<48,000 yuan had significantly higher nonadherence rates than those aged 70--74 years, with high school degree or above, and whose annual household income was 48,000--68,399 yuan.

[Table 2](#t2-ppa-12-803){ref-type="table"} presents the clinical characteristics of patients. This shows that over half of the patients had hypertensive-related complications for \>10 years (63.6%, 60.9%). Half of the patients had one or two comorbidities (56.8%). Approximately two-thirds of the patients took one antihypertensive medication (71.2%). Over half of them were either asymptomatic (37.7%) or had experienced just a mild discomfort (45.8%). Furthermore, only one-third of the patients checked their blood pressure regularly (37.0%), and only a few of them checked their health regularly (27.2%). More than half of the patients were not able to achieve a normal blood pressure (59.8%), and a few of them were trustful of the general practitioners (27.6%). Patients without hypertension-related complications, those with shorter duration of hypertension, those who had not checked their health or blood pressure regularly, those without diabetes, those taking fixed-dose combination medications, those taking traditional medications, and those with uncontrolled blood pressure were more likely nonadherent to their antihypertensive medication regimen. Moreover, further comparison found that patients with no comorbidities had significantly higher nonadherence rates than those with over three comorbidities (*χ*^2^=7.427, *P*=0.006). Similarly, patients who were uncertain to trust doctors had significantly higher nonadherence rates than those who trust the specialists (*χ*^2^=7.562, *P*=0.006).

Results of the principal component analysis of factors
------------------------------------------------------

This study examined the correlation between all variables (data are shown in the Supplementary material). The results showed strong correlations in many variables besides race. In addition, the questions about comorbidities and drug classes were presented in multiple choice questions in the questionnaire, which could not be used for the principal component analysis. Then we conducted the component analysis with factors except race, comorbidities, and drug classes. The results of the principal component analysis of the factors are shown in [Table 3](#t3-ppa-12-803){ref-type="table"}. This study performed the Kaiser-Meyer-Olkin (KMO) and Bartlett's test of sphericity and found a potential correlation between the factors in this study; thus, it was fit to conduct a factor analysis (KMO value is 0.650, Bartlett's test *P*-value \<0.001). This study extracted nine common factors, that is, severity of disease, family, community management, individual factor, social factor, health status, gender, treatment, and economic status, and the cumulative variance contribution rates reached 63.625%. The initial eigenvalues for all nine factors were 2.475, 2.334, 1.697, 1.392, 1.22, 1.193, 1.059, 1.017, and 0.974; all of them were \>0.5. The first common factor represents the following five variables: complication, number of comorbidities, outpatient medical reimbursement, duration, and self-reported severity of hypertension. The second common factor could explain the following three variables: marital status, family members, and annual household income. Similarly, the third common factor represents blood pressure, regular clinical check, and regular blood pressure check. Moreover, the fourth common factor indicates the patient's residence and age. The fifth common factor comprises patient's educational level and employment. The sixth common factor reflects only self-reported health status. Gender is mainly explained by the seventh factor. The eighth common factor reflected the numbers of drugs, health service utilizations in past year, and trust in different doctors. The last common factor explains the underprivileged solely.

Factors related to nonadherence in the logistic regression analysis
-------------------------------------------------------------------

[Table 4](#t4-ppa-12-803){ref-type="table"} presented the common factors that were associated with medication nonadherence; this study found that severity of disease, community management, and patients with diabetes had a statistically significant negative association with nonadherence (*P*\<0.05). Those who had no complications, had no comorbidities, had not availed the outpatient medical reimbursement, had a shorter duration of hypertension, and had slight symptoms of hypertension were more likely non-adherent, whose nonadherence rate was 0.654 times lower than that of patients who had complications, had comorbidities, had availed the outpatient medical reimbursement, had a longer duration of hypertension, and had serious symptoms of hypertension. Similarly, patients with uncontrolled blood pressure and those without regular health or blood pressure check were more likely nonadherent, whose nonadherence rate was 0.731 times lower than that of patients with controlled blood pressure and those with regular health or blood pressure check. The nonadherence rate of patients with diabetes was 0.656 times lower than that of patients without diabetes. Taking traditional medicines was positively associated with nonadherence. This study found that severity of disease was the main factor associated with medication nonadherence.

Discussion
==========

Medication adherence is a key factor in achieving blood pressure control in patients with hypertension. Hence, finding the key factor affecting adherence to antihypertensive medications among community-managed patients with hypertension is important in improving the medication adherence. Prior studies have found that community management is one of the main factors that influenced the effects of treatment and blood pressure control in patients with hypertension. This study extracted nine common factors based on principal component analysis. Further logistic regression analysis found severity of disease factor, community-managed factor, taking traditional medications, and patients with diabetes as factors associated with antihypertensive medication nonadherence. We found that community management could increase the medication adherence in hypertensive patients; hence, we should insist community management in hypertensive patients and constantly improve management measures, improving patients' medication adherence and health outcomes.

Similar to prior studies, this study found that severity of disease factor is one of the factors of adherence in our results (OR=0.654, *P*\<0.001). Hypertension is largely asymptomatic. Prior studies reported that patients with more chronic diseases, those having hypertension-related complications, or those with a longer duration of hypertension more likely received a regular care, understood the importance of adherence, and developed good habits of taking antihypertensive medications; therefore, their medication adherence improved.[@b30-ppa-12-803],[@b46-ppa-12-803] The results of this study were consistent with that of the previous studies. In China, the outpatient medical reimbursement policy was developed for chronic patients with complications; thus, utilization of this reimbursement policy is reflective of the severity of patients' diseases. Patients who availed the policy have the privilege to receive a 60%--80% reimbursement of the medication cost combined with a coinsurance at a limit of 1,500--2,000 yuan each year. This study used principal component analysis and found that the outpatient reimbursement policy was developed based on the severity of patients' diseases; thus, this policy can relieve patients' financial burden to some extent and improve patients' medication adherence. Our results are consistent with the findings of other studies.[@b47-ppa-12-803] Meanwhile, these results would warn us whether patients with mild hypertension should be covered by the outpatient reimbursement policy or not; the feasibility could be explored in further studies.

This study revealed that community management increased patients' medication adherence. Shaik et al found that patients who were under poor community management were nonadherent to antihypertensive medication regimen.[@b30-ppa-12-803] We also found that patients who do not have regular clinical and blood pressure checks and those who were not able to control their blood pressure were more likely nonadherent to their medication regimen. Thus, general practitioners should improve the standardized management and health education for patients with hypertension. In this study, around one-third of the hypertension patients with the comorbidity of diabetes were managed in the community due to hypertension and diabetes in 2009. The method used by general practitioners in managing patients with diabetes is the same as that used in patients with hypertension. One study conducted a survey on individuals with hypertension in Medicaid and reported that the comorbidities of diabetes were associated with decreased nonadherence to antihypertensive medications (OR=0.76, *P*\<0.0001).[@b27-ppa-12-803] We also found that patients with diabetes were adherent to their antihypertensive medications (OR=0.656, *P*\<0.05). There maybe two reasons for this: if patients have both hypertension and diabetes, they will be dual managed by primary health-care providers in China, that is, these patients will recieve hypertension related community management and also diabetes related community management. The community management efforts for them are reinforced, potentially there will be improvements on medication adherence.

To our surprise, in this literature, only 27.6% of the patients trusted their general practitioners, and 54.3% of them placed more trust in their specialists. In 2016, a community family physician model was put into force in China, which formed a service team composed of clinicians, general practitioners or village doctors, community nurses, and public health doctors. Patients with hypertension, patients with diabetes, elderly, and other target population were covered as a matter of priority. As the community family physician model was carried out, acceptance, trust, and compliance to primary health care institutions were improved in patients with hypertension living in Xinjiang, which is a good advantage for primary health care providers to manage and educate patients with hypertension.[@b48-ppa-12-803]

Another important finding was that patients who took traditional medications were considered nonadherent. This result was consistent with the findings of other studies.[@b49-ppa-12-803]--[@b51-ppa-12-803] About 4.3% of the patients took traditional medications to control their blood pressure. Accordingly, 91.6% of the patients used *Apocynum venetum*. *A. venetum* is not included in the list of recommended antihypertensive medications. We found that some patients took *A. venetum* either as a tea or as a preparation to replace other antihypertensive medications. This made the patients' medication regimen complicated as the *A. venetum* had potentially harmful effects. This may be one of the factors contributing to the poor medication adherence among patients with hypertension who take traditional medications.

This study had several limitations. We could not perform the study to compare the adherence of patients with hypertension managed by community or not, because control group without community management was difficulty to be found in China. We could conduct further study to compare adherence of those with hypertension with short-time community management and those with long-time community management so as to explore the relationship between the adherence and community management through cohort study.

Conclusion
==========

The data from this study showed that patients with less severity of diseases, those having poor community management, those without diabetes, and those who took traditional medications were nonadherent to their antihypertensive medication regimen. Community management plays an important role in improving the patients' medication-taking behavior. Unlike the socioeconomic and disease determinants that can be difficult to change, regular provision of medication instructions and improved community management services at the community level can potentially reduce nonadherence. Managing patients with mild hypertension is the main focus of community health care providers to strengthen their standardized management and prevent the occurrence of complications and other adverse outcomes. Professional quality training of general practitioners should be strengthened to improve their patients' trust. This study evaluated the factors affecting medication adherence among patients with hypertension living in Xinjiang, with some references to areas with poor health resources and underdeveloped economic conditions.
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###### 

Adherence level based on sociodemographic characteristics

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Demographic characteristics        Total\      Adherence\   Nonadherence\   *χ*^2^   *P*-value                   
                                     (n=1,916)   (n=1,629)    (n=287)                                              
  ---------------------------------- ----------- ------------ --------------- -------- ----------- ------ -------- -------------------------------------------------
  Age (years)                                                                                             12.564   0.014[a](#tfn1-ppa-12-803){ref-type="table-fn"}

   35--64                            249         13.0         203             81.5     46          18.5            

   65--69                            352         18.4         287             81.5     65          18.5            

   70--74                            514         26.8         458             89.1     56          10.9            

   75--80                            518         27.0         439             84.7     79          15.3            

   \>80                              283         14.8         242             85.5     41          14.5            

  Gender                                                                                                  2.829    0.093

   Male                              762         39.8         635             83.3     127         16.7            

   Female                            1,154       60.2         994             86.1     160         13.9            

  Race                                                                                                    0.319    0.572

   Han                               1,874       97.8         1,592           85.0     282         15.0            

   Others                            42          2.2          37              88.1     5           11.9            

  Residence                                                                                               4.549    0.033[a](#tfn1-ppa-12-803){ref-type="table-fn"}

   Urban                             583         30.4         511             87.7     72          12.3            

   Rural                             1,333       69.6         1,118           83.9     215         16.1            

  Marital status                                                                                          0.339    0.560

   Married                           1,520       79.3         1,296           85.3     224         14.7            

   Others                            396         20.7         333             84.1     63          15.9            

  Educational level                                                                                       12.004   0.007[a](#tfn1-ppa-12-803){ref-type="table-fn"}

   Illiterate                        727         37.9         623             85.7     104         14.3            

   Primary school                    632         33.0         539             85.3     93          14.7            

   Middle school                     356         18.6         285             80.1     71          19.9            

   High school or above              201         10.5         182             90.5     19          9.5             

  Family members                                                                                          0.018    0.893

   1                                 245         12.8         209             85.3     36          14.7            

   \>1                               1,671       87.2         1,420           85.0     251         15.0            

  Underprivileged                                                                                         0.281    0.596

   No                                1,840       96.0         1,566           85.1     274         14.9            

   Yes                               76          4.0          63              82.9     13          17.1            

  Annual household income (yuan)                                                                          7.799    0.020[a](#tfn1-ppa-12-803){ref-type="table-fn"}

   \<48,000                          606         31.6         499             82.3     107         17.7            

   48,000--68,399                    661         34.5         581             87.9     80          12.1            

   ≥68,400                           649         33.9         549             84.6     100         15.4            

  Employment                                                                                              4.944    0.084

   Unemployed                        55          2.9          43              78.2     12          21.8            

   Employed                          85          4.4          67              78.8     18          21.2            

   Retired                           1,776       92.7         1,519           85.5     257         14.5            

  Outpatient medical reimbursement                                                                        11.395   0.001[a](#tfn1-ppa-12-803){ref-type="table-fn"}

   No                                1,348       70.4         1,122           83.2     226         16.8            

   Yes                               568         29.6         507             89.3     61          10.7            
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------

**Note:**

*P*\<0.05.

###### 

Clinical characteristics of patients with hypertension

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Clinical characteristics                         Total\      Adherence\   Nonadherence\   *χ*^2^   *P*-value                   
                                                   (n=1,916)   (n=1,629)    (n=287)                                              
  ------------------------------------------------ ----------- ------------ --------------- -------- ----------- ------ -------- -------------------------------------------------
  Self-reported health status                                                                                           4.705    0.095

    (Very) Poor                                    352         18.4         310             88.1     42          11.9            

   Average                                         873         45.6         745             85.3     128         14.7            

   Well                                            691         36.1         574             83.1     117         16.9            

  Self-reported severity of hypertension                                                                                1.624    0.654

   Asymptomatic                                    722         37.7         619             85.7     103         14.3            

   Mild discomfort                                 877         45.8         736             83.9     141         16.1            

   Moderate discomfort                             264         13.8         228             86.4     36          13.6            

   Extreme discomfort                              53          2.8          46              86.8     7           13.2            

  Complication                                                                                                          9.040    0.003[a](#tfn2-ppa-12-803){ref-type="table-fn"}

   No                                              697         36.4         570             81.8     127         18.2            

   Yes                                             1,219       63.6         1,059           86.9     160         13.1            

  Number of comorbidities                                                                                               7.423    0.024[a](#tfn2-ppa-12-803){ref-type="table-fn"}

   0                                               331         17.3         269             81.3     62          18.7            

   1 or 2                                          1,089       56.8         923             84.8     166         15.2            

   ≥3                                              496         25.9         437             88.1     59          11.9            

  Comorbidity                                                                                                                    

   Patients with diabetes                          599         31.3         533             89.0     66          11.0   10.734   0.001[a](#tfn2-ppa-12-803){ref-type="table-fn"}

   Patients with heart diseases                    1,018       53.1         877             86.1     141         13.9   2.172    0.141

   Patients with cerebrovascular diseases          650         33.9         562             86.5     88          13.5   1.603    0.205

  Duration (years)                                                                                                      33.369   0.000[a](#tfn2-ppa-12-803){ref-type="table-fn"}

   1--4                                            294         15.3         221             75.2     73          24.8            

   5--9                                            455         23.7         378             83.1     77          16.9            

   ≥10                                             1,167       60.9         1,030           88.3     137         11.7            

  Numbers of drugs                                                                                                      3.536    0.171

   1                                               1,364       71.2         1,150           84.3     214         15.7            

   2                                               470         24.5         404             86.0     66          14.0            

   ≥3                                              82          4.3          75              91.5     7           8.5             

  Drug classes                                                                                                                   

   Calcium channel blocker                         1,256       65.6         1,080           86.0     176         14.0   2.674    0.102

   ACE inhibitor                                   242         12.6         203             83.9     39          16.1   0.281    0.596

   ARB                                             314         16.4         276             87.9     38          12.1   2.441    0.118

   β-Blocker                                       339         17.7         300             88.5     39          11.5   3.905    0.048[a](#tfn2-ppa-12-803){ref-type="table-fn"}

   Diuretic                                        85          4.4          73              85.9     12          14.1   0.052    0.820

   Fixed-dose combinations                         148         7.7          116             78.4     32          21.6   5.557    0.018[a](#tfn2-ppa-12-803){ref-type="table-fn"}

   Traditional medicines                           83          4.3          63              75.9     20          24.1   5.663    0.017[a](#tfn2-ppa-12-803){ref-type="table-fn"}

  Regular clinical check                                                                                                11.964   0.001[a](#tfn2-ppa-12-803){ref-type="table-fn"}

   No                                              1,395       72.8         1,162           83.3     233         16.7            

   Yes                                             521         27.2         467             89.6     54          10.4            

  Regular blood pressure check                                                                                          11.939   0.001[a](#tfn2-ppa-12-803){ref-type="table-fn"}

   No                                              1,208       63.0         1,001           82.9     207         17.1            

   Yes                                             708         37.0         628             88.7     80          11.3            

  Blood pressure                                                                                                        13.693   0.000[a](#tfn2-ppa-12-803){ref-type="table-fn"}

   Uncontrolled                                    1,146       59.8         946             82.5     200         17.5            

   Controlled                                      770         40.2         683             88.7     87          11.3            

  Trust in different doctors                                                                                            8.057    0.018[a](#tfn2-ppa-12-803){ref-type="table-fn"}

   Specialist                                      1,040       54.3         897             86.3     143         13.8            

   General practitioner                            529         27.6         454             85.8     75          14.2            

   Uncertain                                       347         18.1         278             80.1     69          19.9            

  Health service utilizations in the past 1 year                                                                        0.002    0.965

   No                                              1,464       76.4         1,245           85.0     219         15.0            

   Yes                                             452         23.6         384             85.0     68          15.0            
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**Note:**

*P*\<0.05.

**Abbreviations:** ACE, angiotensin-converting enzyme; ARB, angiotensin II receptor blocker.

###### 

Coefficient of factor loading and total variance explained in principal component analysis

  Variables                                        F1           F2           F3          F4           F5           F6           F7           F8           F9
  ------------------------------------------------ ------------ ------------ ----------- ------------ ------------ ------------ ------------ ------------ -----------
  Complication                                     **0.760**    −0.122       −0.034      0.016        −0.116       −0.169       0.102        0.298        −0.041
  Number of comorbidities                          **0.613**    −0.186       −0.070      0.120        0.014        0.152        0.102        **0.318**    −0.178
  Outpatient medical reimbursement                 **0.604**    0.105        0.015       −0.030       −0.136       −**0.422**   0.154        0.212        −0.004
  Duration                                         **0.447**    −0.080       0.012       −0.326       0.122        0.080        **0.389**    −0.100       0.112
  Self-reported severity of hypertension           **0.437**    −0.247       −0.158      0.193        0.002        0.325        −0.235       0.013        −0.26
  Marital status                                   0.149        **0.785**    −0.198      0.186        0.168        0.122        −0.042       −0.016       0.073
  Family members                                   0.194        **0.734**    −0.223      0.179        0.185        0.241        0.013        −0.002       0.152
  Annual household income                          0.279        **0.670**    −0.014      −0.152       0.230        0.143        0.023        0.016        0.040
  Blood pressure                                   0.063        0.098        **0.796**   0.165        0.144        0.026        −0.048       0.123        0.017
  Regular clinical check                           0.074        0.070        **0.716**   0.262        0.118        0.011        −0.019       −0.013       0.105
  Regular blood pressure check                     0.210        0.093        **0.561**   0.002        −0.011       0.036        −0.130       −0.036       −0.077
  Residence                                        −0.117       −0.096       −0.251      **0.566**    0.214        −0.379       −0.031       0.269        0.121
  Age                                              0.237        −0.263       0.015       −**0.536**   0.223        0.017        −**0.448**   0.085        0.203
  Educational level                                0.015        **0.473**    0.170       −0.180       −**0.547**   −0.117       −0.019       −0.045       −0.285
  Employment                                       0.184        −0.019       0.016       −0.388       **0.483**    −0.295       −0.122       −0.112       0.144
  Self-reported health status                      −**0.323**   0.190        0.083       −0.041       0.080        −**0.476**   **0.338**    0.094        0.138
  Gender                                           0.070        −**0.448**   0.078       0.215        0.315        **0.307**    **0.507**    −0.220       0.015
  Numbers of drugs                                 **0.339**    0.038        0.003       −0.098       −0.345       −0.019       0.272        −**0.427**   0.262
  Health service utilizations in the past 1 year   **0.334**    −0.066       −0.003      0.348        −0.166       −0.110       −0.270       −**0.395**   0.214
  Trust in different doctors                       −**0.364**   0.130        0.101       −0.277       −0.039       0.310        0.219        **0.382**    −0.069
  Underprivileged                                  −0.050       −0.131       0.022       0.032        −**0.376**   0.286        −0.047       **0.345**    **0.720**
  Initial eigenvalues                              2.475        2.334        1.697       1.392        1.220        1.193        1.059        1.017        0.974
  Cumulative %                                     11.786       22.903       30.985      37.615       43.423       49.102       54.143       58.986       63.625

**Notes:** Bold entries reflect the information of specific original variables that each of factors (F1--F9) included. Some original variables' information also marked as bold entries, because they have a higher value in the corresponding factors, although these original variables were included in other factors at last based on highest value. F1 reflects complication, number of comorbidities, outpatient medical reimbursement, duration, self-reported severity of hypertension, named severity of disease factor; F2 reflects marital status, family members, annual household income, named family factor; F3 reflects blood pressure, regular clinical check, regular blood pressure check, named community management factor; F4 reflects residence and age, named individual factor; F5 reflects educational level and employment, named social factor; F6 reflects self-reported health status, named health status factor; F7 reflects gender, named gender factor; F8 reflects number of drugs, health service utilization in the past 1 year,and trust in different doctors, named treatment factor; F9 reflects underprivileged, named economic status factor.

Abbreviation: F, factor.

###### 

Common factors associated with medication nonadherence using a binary logistic regression analysis

  Associated factors          Crude OR (95% CI)      *P*-value                                         Adjusted OR[b](#tfn7-ppa-12-803){ref-type="table-fn"}(95% CI)   *P*-value
  --------------------------- ---------------------- ------------------------------------------------- --------------------------------------------------------------- -------------------------------------------------
  Patients with diabetes      0.614 (0.458, 0.824)   0.001[a](#tfn6-ppa-12-803){ref-type="table-fn"}   0.656 (0.479, 0.898)                                            0.008[a](#tfn6-ppa-12-803){ref-type="table-fn"}
  β-Blocker                   0.697 (0.486, 0.999)   0.049[a](#tfn6-ppa-12-803){ref-type="table-fn"}   0.979 (0.609, 1.573)                                            0.929
  Fixed-dose combinations     1.637 (1.083, 2.474)   0.019[a](#tfn6-ppa-12-803){ref-type="table-fn"}   1.638 (0.955, 2.808)                                            0.073
  Traditional medicines       1.862 (1.108, 3.130)   0.019[a](#tfn6-ppa-12-803){ref-type="table-fn"}   2.096 (1.097, 4.005)                                            0.025[a](#tfn6-ppa-12-803){ref-type="table-fn"}
  Severity of disease (F1)    0.702 (0.617, 0.799)   0.000[a](#tfn6-ppa-12-803){ref-type="table-fn"}   0.654 (0.538, 0.795)                                            0.000[a](#tfn6-ppa-12-803){ref-type="table-fn"}
  Family (F2)                 1.016 (0.896, 1.153)   0.802                                             1.013 (0.886, 1.157)                                            0.853
  Community management (F3)   0.743 (0.649, 0.850)   0.000[a](#tfn6-ppa-12-803){ref-type="table-fn"}   0.731 (0.635, 0.842)                                            0.000[a](#tfn6-ppa-12-803){ref-type="table-fn"}
  Individual factor (F4)      1.101 (0.972, 1.248)   0.131                                             1.090 (0.956, 1.242)                                            0.197
  Social factor (F5)          0.896 (0.793, 1.013)   0.078                                             0.917 (0.798, 1.054)                                            0.223
  Health status (F6)          0.989 (0.872, 1.122)   0.866                                             0.990 (0.868, 1.130)                                            0.883
  Gender (F7)                 0.897 (0.791, 1.017)   0.088                                             0.889 (0.776, 1.019)                                            0.090
  Treatment (F8)              1.060 (0.935, 1.202)   0.360                                             1.074 (0.917, 1.258)                                            0.376
  Economic factor (F9)        0.961 (0.845, 1.093)   0.545                                             0.930 (0.813, 1.065)                                            0.294

**Notes:**

*P*\<0.05.

The regression model was adjusted for residence, patients with heart diseases, patients with cerebrovascular diseases, calcium channel blocker, ACE inhibitor, ARB, and diuretic.

**Abbreviations:** OR, odds ratio; ACE, angiotensin-converting enzyme; ARB, angiotensin II receptor blocker; F, factor.

[^1]: These authors contributed equally to this work
